Form 4 for SMMT Summit Therapeutics Inc.
Accepted 2022-08-18 00:00:00 ET · period of report 2022-08-16 · accession 0001387131-22-008888 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-18 | 2022-08-16 | SMMT | DUGGAN ROBERT W | CEO, Dir | P - Purchase | $0.97 | +94.85M | 162.53M | +140% | +$92.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-16 | P | A | 94,849,203 | $0.97 | 162,532,792 | D | — | — | (F1) Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. |